OTOP3 functions as an oncogenic regulator of ferroptosis-mediated colorectal cancer progression
Genes & Genomics · 2025
DOI: 10.1007/s13258-025-01657-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes & Genomics, 2025. Verfasst von Yu Jin Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Korean Medicine, Kyung Hee University, Seoul, 02447, Korea. Hauptthemen laut MEDLINE: Ferroptosis, Colorectal Neoplasms. Die Arbeit nennt 45 Literaturangaben. Gefördert von: National Research Foundation of Korea (NRF).
Abstract (Originalsprache)
BACKGROUND: OTOP3, a proton channel located at 17q25.1, drives colorectal cancer growth by enhancing c-Myc stability and inhibiting ferroptosis through GPX4 regulation. Inhibition of OTOP3 suppresses CRC proliferation via c-Myc destabilization, ROS accumulation, and lipid peroxidation, while modulating metabolic shifts linked to the Warburg effect. These findings position OTOP3 as a novel therapeutic target for CRC by disrupting oncogenic signaling and ferroptosis resistance. OBJECTIVE: To investigate OTOP3's role in CRC growth/metastasis and its link to ferroptosis and metabolic reprogramming. To evaluate OTOP3 targeting as a therapeutic strategy. METHODS: Colorectal cancer (CRC) cell lines were transfected with OTOP3 siRNA to suppress gene expression, followed by cell viability assays to assess proliferation changes. Western blotting quantified c-Myc and GPX4 levels, while fluorescent probes measured ROS accumulation and lipid peroxidation. Ferroptosis induction was validated using ferroptosis inhibitors, and glycolytic activity was analyzed via glycolysis-related gene expression and lactate production assays. RESULTS: OTOP3 inhibition destabilized c-Myc, suppressed proliferation, and induced ferroptosis via GPX4 reduction, ROS accumulation, and lipid peroxidation. Altered glycolysis factors indicated enhanced Warburg effect. CONCLUSION: Our study provides compelling evidence that targeting OTOP3 effectively suppresses colorectal cancer proliferation by reducing c-Myc protein stability and inducing ferroptosis. These effects are closely associated with metabolic shifts characteristic of the Warburg effect, emphasizing OTOP3 as a potential therapeutic target in colorectal cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Korean Medicine, Kyung Hee University, Seoul, 02447, Korea.
- Department of Life Science and Biochemical Engineering, Sunmoon University, Asan, 31460, Korea.
- Low-Carbon Transition R&D Department, Korea Institute of Industrial Technology, Cheonan-si, 31056, Korea.
- College of Korean Medicine, Kyung Hee University, Seoul, 02447, Korea. johnsperfume@gmail.com.
ORCID-Profile: Ji Hoon Jung
Förderung
- National Research Foundation of Korea (NRF)
Zitieren
APA
Lee, Y. J., Han, Y. J., Oh, J. J., Kim, S. Y., Cho, J., & Jung, J. H. (2025). OTOP3 functions as an oncogenic regulator of ferroptosis-mediated colorectal cancer progression. Genes & Genomics. https://doi.org/10.1007/s13258-025-01657-4
Vancouver
Lee YJ, Han YJ, Oh JJ, Kim SY, Cho J, Jung JH. OTOP3 functions as an oncogenic regulator of ferroptosis-mediated colorectal cancer progression. Genes & Genomics. 2025. doi:10.1007/s13258-025-01657-4
BibTeX
@article{Lee2025,
author = {Lee, Yu Jin and Han, Yeo Jeong and Oh, Je Joung and Kim, Seung-Young and Cho, Jaehoon and Jung, Ji Hoon},
title = {OTOP3 functions as an oncogenic regulator of ferroptosis-mediated colorectal cancer progression},
journal = {Genes & Genomics},
year = {2025},
doi = {10.1007/s13258-025-01657-4}
}
EUVIMED